Delivery Order SPE2DB24D1104-SPE2DB25FYBR2
Award Date
6/3/25
Potential Completion Date
6/4/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $16,243.70 and is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The delivery order has an ultimate completion date of June 11, 2025. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $137,827.34, is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a completion date of June 4, 2025. The contract is not set aside and was awarded on June 3, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, with a ceiling value of $11,731.35 and a period of performance ending on June 13, 2025. The contract is not set aside and was awarded on June 12, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award and holds a...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $12,078.15 and a performance period ending on June 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $11,731.35 and a period of performance through May 23, 2025. The contract is not set aside and is an open competition award. This contract is associated with a larger Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML. The award has a ceiling value of $3,910.45 and an ultimate completion date of May 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,293.47, is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $26,077.33 and a period of performance through March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
This is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The award has a ceiling value of $3,910.45 and a completion date of June 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to supply a wide range of pharmaceutical products...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $26,316.91, is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a medication, with a performance period through May 8, 2025. The contract is not set-aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...